Anthera Pharmaceuticals | Evaluate

November 04, 2016

Upcoming events – Nucala in new indications and blisibimod in lupus

UCB adds to the lupus casualty list with epratuzumab failure

April 16, 2015

Therapy focus – Beyond blood pressure control for IgA nephropathy

April 10, 2015

Good times roll in Q1 as mid and small cap winners outnumber losers

March 14, 2014

Upcoming events: Insmed and Anthera hope new data will overcome past setbacks

January 09, 2013

Sarepta joins the big league as best-performing 2012 share

October 10, 2012

Wockardt and Arena lead small-cap gainers through nine months

July 18, 2012

Anthera springs back to life but more surprises likely

July 05, 2012

Therapeutic focus – Late stage lupus pipeline sparse but potentially valuable

July 04, 2012

Obesity turnaround drives small cap gainers in H1

April 05, 2012

Vivus, Amylin and Threshold notable small cap gainers in Q1

Load More